関連する実験動画
Updated: May 26, 2026

09:45
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
Myc駆動型腫瘍発生には,SUMOylationに依存した転写サブプログラムが必要です
Jessica D Kessler1, Kristopher T Kahle, Tingting Sun
1Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
まとめ
SUMO活性化酵素 (SAE1/2) を標的にすることは,Myc駆動がんにおける合成致死性を引き起こします. SAE1/2を阻害すると,Myccが破壊される.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- Mycは,ヒトのがんではしばしば制御不能な重要な腫瘍性転写因子である.
- Mycの腫瘍性プログラムをサポートする経路を特定することは,標的治療の開発に不可欠です.
研究 の 目的:
- 全ゲノムRNA干渉スクリーンを用いて,Mycで合成的に致命的な遺伝子を識別する.
- Myc駆動がんにおけるSUMO活性化酵素 (SAE1/2) の役割を調査する.
主な方法:
- Myc合成による致死性遺伝子を特定するための全ゲノムRNA干渉スクリーン.
- Myc過活性化への影響を観察するためにSAE2の無活性化.
- SUMOylation依存型Mycスイッチ (SMS遺伝子) の分析と,ミトーシス・スパインドルの機能におけるその役割.
- マウスにおけるMyc依存性腫瘍増殖に対するSAE2要件の評価.
- Myc-高いヒト乳がんの遺伝子発現分析.
主要な成果:
- SUMO活性化酵素 (SAE1/2) の役割は,Myc合成の致死性遺伝子として発見されました.
- SAE1/2の酵素活性の喪失は,Myc.で合成的致死性を引き起こす.
- SAE2の無活性化により,Mycの過活性化により,ミトスの破滅と細胞死を引き起こす.
- SAE2の阻害により,Mycの転写プログラムが活性化から抑制に切り替わります.
- SUMOylation依存型Mycスイッチ (SMS遺伝子) のサブセットは,ミトーシススパインドル機能とMycの腫瘍性プログラムに不可欠です.
- マウスのMyc依存性腫瘍の成長にはSAE2が必要である.
- 人間の乳がんにおけるSAE1およびSAE2の低濃度は,より長い転移のない生存期間と相関しています.
結論:
- 特にSAE1/2を標的としたSUMOylationの抑制は,Myc駆動がんに対する潜在的な治療戦略を示しています.
- SUMOylationに依存するMycスイッチメカニズムを理解することは,がんの生物学に関する洞察を提供します.
- SAE1/2を標的とした治療は,Mycに依存したヒトの悪性腫瘍の治療に有望な道である可能性があります.
関連する概念動画
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Combinatorial Gene Control
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

